Viewing Study NCT06214195


Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2025-12-30 @ 1:24 AM
Study NCT ID: NCT06214195
Status: RECRUITING
Last Update Posted: 2024-01-19
First Post: 2023-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module